Adoption of Biosimilars in the United States and Europe
Bruce A. Feinberg, DO; Hope S. Rugo, MD; Brandon Shank, PharmD, MPH, BCOP; and Marcus H. Snow, MD, consider the adoption of granulocyte-colony stimulating factors and explore how dosage and administration considerations may affect their use in practice.
August 23, 2017
View Text Version